Sepracor Inc. licenses the rights to a safer heartburn drug to J&J

Article Abstract:

Johnson and Johnson has received licensing rights for a potentially safer from of the popular heartburn medication Propulsid from Sepracor Inc. in exchange for undisclosed royalties. The drug, which had sales of over $1 billion in 1997, had been referred to federal regulators from the Food and Drug Admnistration as a possible cause of fatal heart-rhythm problems in patients. Propulsid has not been tested on human subjects but animal studies performed by Sepracor have provided promising results.

Comment:

Has given licensing rights for safer form of heartburn medication Propulsid to Johnson & Johnson for undisclosed royalties

Strategic alliances, Licensing/Sales Agreements, Digestive & Genito-Urinary Preps, Johnson & Johnson, Sepracor Inc., Article

---

Interneuron's Redux study shows heart effects

Article Abstract:

Interneuron Pharmaceuticals Inc. financed further study of its diet pill Redux and finds that the heart-valve problems that were reported do exist but not to the extent first thought. Meanwhile, the company has already offered to settle all lawsuits relating to the pill for $100 million. The FDA asked for a recall of the drug in September 1997.

Product information, Pharmaceutical preparations, Metabolic Agents, Research, Drugs, Safety and security measures, Pharmaceutical industry, Abstract, Interneuron Pharmaceuticals Inc., IPIC

---

Similar abstracts:

• Abstracts: The search services want your eyes to find no reason to wander
• Abstracts: GPU Inc. is set to sell 23 power plants to Sithe Energies in $1.67 billion deal
• Abstracts: Northwest affiliate agrees to comply with US order to reinstate service. UAL girds for vote on unionization of ticket agents
• Abstracts: Healtheon struggles in effots to remedy doctors' paper plague. Excite posts loss but revenue gain tops expectations
• Abstracts: Cendant's board agrees to overhaul top options deals. Cendant ends pact to buy American Bankers

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.